Marex Group’s Cellebrite CLBT Stock Holding History

Marex Group’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	+72,000	New	+$952K	﹤0.01%	490
2026 Q1	–	Sell	-33,379	Closed	-$602K	–	1055
2025 Q4	$602K	Buy	+33,379	New	+$599K	﹤0.01%	510
2025 Q2	–	Sell	-13,000	Closed	-$253K	–	701
2025 Q1	$253K	Hold	13,000	–	–	﹤0.01%	507
2024 Q4	$286K	Hold	13,000	–	–	﹤0.01%	459
2024 Q3	$219K	Hold	13,000	–	–	0.01%	456
2024 Q2	$155K	Hold	13,000	–	–	﹤0.01%	535
2024 Q1	$144K	Buy	+13,000	New	+$133K	﹤0.01%	410

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Marex Group's CLBT Position: Q2 2026 in Review

Marex Group opened a new position in Cellebrite (CLBT) in Q2 2026: 72,000 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #490 among its holdings. This is a return to the name: Marex Group previously reported a position in CLBT as recently as Q4 2025.

Marex Group first reported a position in CLBT in Q1 2024 and has held it in 7 quarters since. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Marex Group held 72,000 shares of Cellebrite worth $1.05M as of Q2 2026.
Cellebrite was a new Marex Group position in Q2 2026.
Cellebrite made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #490 holding.
Marex Group first reported a position in Cellebrite in Q1 2024 and has held it in 7 quarters since.
200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.